Vanderbilt Ingram Cancer Center

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read More

Vanderbilt-Ingram Cancer Center's Green Hills Clinic is located at 3810 Bedford Ave., Suite 100. (Vanderbilt University) Vanderbilt-Ingram Cancer Center will host the community series event “A Taste of Mindfulness” beginning at 6 p.m. Tuesday, April 17, at VICC’s Green Hills clinic, 3810 Bedford Ave., Suite… Read More

Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk. Read More

The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, director of drug discovery at Vanderbilt-Ingram Cancer Center. They will discuss… Read More

A molecule detectable in urine may be helpful in diagnosing colon cancer. Read More

Glen and Tracy Parsons (front) and their children (Daniel Dubois/Vanderbilt) At 10:30 p.m., the phone rang and woke Tracy Parsons from a sound sleep. She thought the call must be from her husband, Glen, a truck driver who was on the road that night. But caller ID read “Department… Read More

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. Read More

Jeffrey Sosman (Vanderbilt) Jeffrey Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance. Sosman is among the Dream Team’s principal investigators who… Read More

Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read More

(photo by Cynthia Manley/Gilda's Club Nashville) Make your dream to walk or run the Country Music Half-Marathon in April a reality. Health Plus, the Vanderbilt-Ingram Cancer Center, the Vanderbilt Dayani Center and Gilda’s Club of Nashville are partnering to offer a 16-week comprehensive training program designed to help you… Read More

(Image courtesy of Alan LeQuire) Nashville’s Musica statue will be bathed in purple light during the Paint Nashville Purple event for pancreatic cancer awareness at 6:30 p.m. Tuesday, Nov. 1, at the roundabout on Demonbreun Street. Linda’s Hope, a local nonprofit organization for pancreatic cancer awareness and… Read More

Dr. Emily Kurtz (left) of the Vanderbilt Heart and Vascular Institute appears in new ads for the Promise of Discovery campaign. (Vanderbilt University) Vanderbilt University Medical Center’s award-winning “Promise of Discovery” initiative continues with the creation of additional story lines and the launch of a new series… Read More

Walking, running, pushing a baby carriage or strolling with your dog – all of these activities will be encouraged during this year’s Greater Nashville Race for the Cure. The annual breast cancer fundraising race/walk will be held Saturday, Oct. 29, at Maryland Farms in Brentwood. The Race for the… Read More

A protein critical in heart development may also play a part in colon cancer progression. Read More

Tracy Barrett (Vanderbilt) Tracy Barrett, senior lecturer in Italian, has written Dark of the Moon, a re-telling of the Theseus myth for young adult readers, published by Harcourt Children’s Books. Leonard Bickman, the Betts Chair and professor… Read More

Photo courtesy of Kjell Oberg The Vanderbilt Neuroendocrine Center is hosting talks by renowned endocrine tumor expert Kjell Oberg of Uppsala University Hospital in Sweden, Oct. 17-19 on the Vanderbilt University Medical Center campus. Oberg, chairman of the Centre of Excellence for Endocrine Tumors, is… Read More

Low folate levels may increase a premenopausal woman’s risk of developing breast cancer. Read More

A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding. Read More